The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Methylphenidate ER Tablets. Procurement details follow.
Methylphenidate ER 18MG, 27MG, 36MG, and 54MG Tablets in 100 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of War, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
The contractor shall provide Methylphenidate ER Tablets (18MG, 27MG, 36MG, 54MG) in 100-count bottles to DLA and VA Pharmaceutical Prime Vendors for distribution to DoD, VA, Indian Health Service, and Bureau of Prisons ordering activities. The contractor must enter into business-to-business agreements with each prime vendor, ensure sufficient inventory for delivery within 15 days of contract performance date, and comply with labeling, bar coding, packaging (child-proof closure, cylindrical bottle), and Drug Supply Chain Security Act requirements. The contractor must also submit quarterly sales reports and remit a 0.5% cost recovery fee.
We post new goods & materials opportunities in Pennsylvania as agencies publish them. Get them in one email — free, and unsubscribe whenever.
"19111""PHILADELPHIA""PA""USA""MEDICAL SUPPLY CHAIN FSGB""700 ROBBINS AVENUE""amendment1.pdf"353267"file"".pdf""1""2026-10-21T18:07:57.62+00:00""3d2ed408a3e04284b92a8877423d0935""public""0""public""5bf05e035da648be9e3d689766cce254""0"3"0""amendment2.pdf"337551"file"".pdf""1""2026-10-21T18:07:57.62+00:00""8917be6ee3e94288a91f57c92c40aad8""public""0""public""942917f97fbf4ff4b1dff7292cca344c""0"2"0""Methylphenidate ER Solicitation final.pdf"1075975"file"".pdf""1""2026-09-23T15:54:28.385+00:00""06f97a23a08443da8ce52cd7c52e19c4""public""0""public""b8d7fbb1e67041ecbfcd7aaa1f0dec5f""0"1"0"Most Pennsylvania work asks for the two below, and the solicitation documents are where it’s stated. One prequalification covers both — on this bid and the next.
A surety’s written statement that it expects to bond you up to a stated amount, subject to final underwriting. It’s what an agency asks to see before they take your bid seriously.
Source: SAM.gov (notice 37bf5530c25b4155a601effe7b1ef8f4), retrieved via the SAM.gov Get Opportunities API. View the official posting, and always confirm requirements and deadlines with the issuing agency.